Total N = 1422 | ECD n = 325 | Non-ECD n = 1097 | p value | |
---|---|---|---|---|
Age at transplant, years | ||||
Mean (SD) | 54 (13) | 59 (11) | 53 (13) | <0.001 |
Women | 503 (35 %) | 105 (32 %) | 398 (36 %) | 0.188 |
Race | ||||
Caucasian (%) | 884 (62 %) | 197 (61 %) | 687 (63 %) | 0.777 |
Asian (%) | 121 (9 %) | 32 (10 %) | 89 (8 %) | |
African-American (%) | 127 (9 %) | 31 (10 %) | 96 (9 %) | |
Aboriginal (%) | 36 (3 %) | 6 (2 %) | 30 (3 %) | |
Other (%) | 236 (17 %) | 56 (17 %) | 180 (16 %) | |
Unknown | 18 | – | – | |
Primary cause of ESRD | ||||
Glomerulonephritis (%) | 328 (29 %) | 68 (26 %) | 260 (31 %) | 0.010 |
Diabetes mellitus (%) | 215 (19 %) | 66 (25 %) | 149 (18 %) | |
Hypertension (%) | 95 (9 %) | 30 (11 %) | 65 (8 %) | |
Other (%) | 474 (43 %) | 97 (37 %) | 377 (44 %) | |
Unknown | 310 | – | – | |
Pre-transplant dialysis time (months) | ||||
Median (Q1–Q3) | 58 (34-85) | 54 (36–76) | 59 (33–86) | 0.075 |
Peak PRA >0 % (%) | 792 (56 %) | 186 (57 %) | 606 (55 %) | 0.134 |
Missing | 122 | – | – | |
Re-graft (%)a | 96 (7 %) | 8 (2 %) | 88 (8 %) | <0.001 |
Comorbidities | ||||
Diabetes mellitus (%) | 491 (35 %) | 144 (44 %) | 347 (32 %) | <0.001 |
Hypertension (%) | 1334 (94 %) | 310 (95 %) | 1024 (93 %) | 0.198 |
Cardiovascular disease (%) | 117 (8 %) | 36 (11 %) | 81 (7 %) | 0.033 |
Mean Charlson comorbidity index (SD)b | 2.6 (1.4) | 2.7 (1.5) | 2.5 (1.4) | 0.03 |